Motus Nova Foot Device for Patients With Hemiplegia

Part of paid clinical trials in Puyallup, Washington.

Sponsor
MultiCare Health System Research Institute
Study ID
NCT07754773
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Cerebral Palsy
  • Hemiplegia
  • Hemiplegic Cerebral Palsy

Eligibility Criteria

Sex
ALL
Age
12 Years - 20 Years
Healthy Volunteers
Not accepted

Interventions

  • Motus Nova Foot — DEVICE
    Motus Nova Foot device used in home therapy to improve gait for individuals with hemiplegia.

Study Details

Individuals with hemiplegia commonly demonstrate gait deviations such as difficulties with heel strike at initial contact, foot drop in swing, asymmetrical limb loading, muscle activation, and balance impairments. This study evaluates whether a therapeutic device (Motus Nova Foot; FDA approved) used in the home setting can increase heel strike, decrease limp, improve foot clearance in swing phase, improve quality of active muscle contraction of the affected limb, and improve balance. The Motus Nova Foot moves the ankle/foot and uses guided computer/video activities to encourage active participation while automatically recording device use and duration.

Key Dates

First listed
Aug 10, 2026
Start date
Sep 30, 2026
Status verified
Aug 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
5 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Impact of Motus Nova Foot on Gait and Balance for Individuals with Hemiplegia
    Participants will complete a home-based intervention using the Motus Nova Foot device for approximately 8-10 weeks. The device provides robot-assisted ankle/foot movement and interactive computer-guided therapeutic activities designed to improve ankle range of motion, strength, motor control, and gait mechanics. Participants are instructed to use the device 20-40 minutes per day, 4-5 days per week. Activities include 3-5 guided tasks targeting dorsiflexion, plantarflexion, and functional ankle control, with the device automatically recording usage and duration. Families receive an initial in-lab device fitting and training session, and research staff provide weekly check-ins (virtual or in-person) for troubleshooting and adherence support. After the intervention phase, participants complete an 8-10-week no-treatment carryover period with no device use to assess retention of gains.

Primary Outcome Measure

Heel strike [ Time Frame: 4 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mary Bridge Children's Therapy Research & Movement LabPuyallupWashington98372
Brenna Brandsma, PT, DPT, PCS
[email protected]
253-697-5268
Sean Brown, PhD
[email protected]
253-697-5402

Find similar trials in Puyallup, WA

By research site
Mary Bridge Children's Therapy Research & Movement Lab· Puyallup, WA

Related Studies